Skip to main content
. 2014 Mar 31;7:145. doi: 10.1186/1756-3305-7-145

Table 2.

CD4 + , CD8 + subtypes of T cells from immunized mice were measured using flow cytometry

Immunization route a Immunization regimen CD4 + (%) b CD8 + (%) b
Intramuscular vaccination
PBS
26.71 ± 1.32
21.67 ± 0.82
 
pVAX1
25.45 ± 1.13
22.37 ± 0.98
 
pVAX1-MEG-CTXA2/B
24.56 ± 1.25
28.54 ± 0.92
Intranasal vaccination
BRD509
25.71 ± 0.64
22.37 ± 0.83
 
BRD509/pVAX1
24.32 ± 1.75
26.34 ± 0.93
 
BRD509/pVAX1-MEG-CTXA2/B
24.68 ± 1.43
30.01 ± 1.78
Intraoral vaccination
BRD509
27.45 ± 1.91
24.38 ± 0.98
 
BRD509/pVAX1
24.32 ± 1.21
30.28 ± 0.53
  BRD509/pVAX1-MEG-CTXA2/B 25.15 ± 1.55 35.55 ± 0.70

aMice were immunized by three immunization routes, intramuscular, intraoral, intranasal, on day 0 and day 14 and day 28 with different immunization regimens.

bThe splenocyte culture supernatants taken from mice (n = 3, each group) 2 weeks after the last immunization were stained with FITC-labeled anti-mouse CD8+ monoclonal antibody and PE-labeled anti-mouse CD4+ monoclonal antibody, T lymphocyte subsets were measured using flow cytometry.

HHS Vulnerability Disclosure